Primex Clinical Laboratories, Inc. and Eric Garofano v. Dana Gordon D/B/A Ignite, Inc.

Court of Appeals of Texas

Primex Clinical Laboratories, Inc. and Eric Garofano v. Dana Gordon D/B/A Ignite, Inc.

DecidedMay 9, 2023

Docket14-22-00703-CV

StatusPublished

This text of Primex Clinical Laboratories, Inc. and Eric Garofano v. Dana Gordon D/B/A Ignite, Inc. (Primex Clinical Laboratories, Inc. and Eric Garofano v. Dana Gordon D/B/A Ignite, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Primex Clinical Laboratories, Inc. and Eric Garofano v. Dana Gordon D/B/A Ignite, Inc., (Tex. Ct. App. 2023).

Pincite

Opinion

Dismissed and Memorandum Opinion filed May 9, 2023

In The

Fourteenth Court of Appeals

NO. 14-22-00703-CV

PRIMEX CLINICAL LABORATORIES, INC. AND ERIC GAROFANO, Appellants V.

DANA GORDON D/B/A IGNITE, INC., Appellee

On Appeal from the 234th District Court Harris County, Texas Trial Court Cause No. 2022-41359

MEMORANDUM OPINION

This appeal is from a judgment signed September 19, 2022. The clerk’s record was filed November 29, 2022. The reporter’s record was filed October 3, 2022. No brief was filed.

On March 23, 2023, this court issued an order stating that unless appellants filed a brief on or before April 24, 2023, the appeal was subject to dismissal without further notice for want of prosecution. See Tex. R. App. P. 42.3(b). Appellants filed no brief or other response. We dismiss the appeal.

PER CURIAM

Panel consists of Justices Bourliot, Hassan, and Poissant.

Free access — add to your briefcase to read the full text and ask questions with AI